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Highlights: 
• FALC stromal cells contribute to the barrier function of the mesothelium 
• CCL19+ FRCs & CXCL13+ cover cells support the functional architecture of FALCs 
• FALC stromal cells create an IL-33 rich environment to support ILC2 function 
• Cover cells secrete RA required for cavity Mφ phenotype & B cell function  
• Innate-immune activation of FALC FRC mediates T-B cell interactions  
 






The serous cavities contain specialised adipose tissues which house small clusters of immune 
cells known as fat-associated lymphoid clusters (FALCs). The continuous flow of fluid from 
the serous cavities through FALCs makes them unique niches for the clearance of fluid phase 
contaminants and initiation of locally protective immune responses during infection and 
inflammation. Development, and activation of FALCs both at homeostasis and following 
inflammation are co-ordinated by the close interaction of mesothelial and fibroblastic stromal 
cell populations with immune cells. In this review we discuss recent developments in FALC 
stromal cell biology and highlight key interactions that occur between FALC stroma and 
immune cells.   
 
Introduction: 
Internal organs are contained in three fluid-filled serous cavities: the peritoneum which 
envelops the abdominal viscera [1] the pleural cavity enclosing the lungs [2] and the 
pericardium which protects and anchors the heart [3]. These cavities are delimited by two 
membranes, the parietal serosa covering the wall of the cavity and the visceral serosa covering 
the organs. Fluid is secreted by the mesothelium lining these membranes ensuring lubrication 
of the serous cavities, free movement of organs and continuous flow of fluid. Fluid is drained 
out of the cavities through stomata found in the mesothelium of certain visceral adipose tissues, 
such as the membranous folds formed by the omentum and mesenteries in the peritoneal cavity, 
the adipose tissue of the mediastinum in the pleural cavity and the adipose tissue of the 
pericardium. Dedicated immunological niches called fat-associated lymphoid clusters 
(FALCs) develop under the intercellular pores formed by stomata [4,5] in the mesothelium of 
these visceral adipose tissues and contribute to the barrier function of the mesothelium and 
immune surveillance of serous cavities. FALCs were first identified in the omentum where, 
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historically, they were called milky spots [6], knowledge of their existence was later expanded 
to include other visceral adipose tissues [7-10]. FALCs are important immune activation and 
co-ordination hubs; possessing some functions akin to lymph nodes but distinct in that they are 
not encapsulated organs, enabling direct and more immediate contact with contaminants 
(pathogens, particulate material, PAMPs, DAMPs) within the cavities in which they reside. 
Recent studies are beginning to unpick the complex interactions between immune and stromal 
cells within adipose organs. The FALCs, as co-ordination hubs for body cavity immune 
responses represent an important site for the analysis of adipose stromal-immune interactions 
that take place just beyond the mucosal frontline.  
 
1 Structure of FALCs and function of FALC stromal cells at homeostasis  
1.1 Structure of FALCs 
FALCs are a critical component of serous innate-B cell function [11]. The recruitment of B 
cells to FALCs is dependent on the homeostatic chemokine CXCL13 [12], which is expressed 
by stromal cells that form a 3-dimensional basket that envelopes FALC B cells [13]. Recent 
work from our lab confirmed that the expression of CXCL13 was limited to the loose lining of 
mesothelial cells covering the serous facing side of FALCs [14]. We called these cells 
CXCL13+ FALC cover cells. In addition to CXCL13, FALC cover cells express 
GP38/Podoplanin and a number of factors involved in the recruitment, adhesion or activation 
of immune cells [14] suggesting that FALC cover cells facilitate the extravasation of immune 
cells between the serous cavities and FALCs. 
A distinct subset of stromal cells expressing the homeostatic chemokine CCL19 is 
found at the heart of the clusters [15]. These stromal cells form a reticular network, expressing 
GP38 and the fibroblastic marker PDGFRα, resembling fibroblastic reticular cells (FRCs) and 
referred to as FALC FRCs. Lymph nodes contain different subsets of FRCs contributing to 
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various structural and functional niches [16,17] including CCL19 expressing reticular cells 
found in the T-cell zone of lymph nodes and called T-reticular cells. While T cells are present 
in FALCs, there is no clear T-cell zone, indicating that FALC FRCs constitute a unique subset 
of lymphoid stromal cells with differing functional capacity to FRCs found within lymph 
nodes.    
FALCs are highly vascularised [18-20] with the endothelial blood vasculature forming 
distinctive convolutions resembling the renal glomeruli. FALCs can support the differentiation 
of high endothelial venules (HEV). HEVs are essential for lymphocyte trafficking in secondary 
organs and in FALCs support the entrance of lymphocytes to the serous cavities from the 
circulation. In addition, HEVs are used by neutrophils to swiftly transit into the peritoneal 
cavity during peritonitis [21]. In contrast to lymph nodes which directly receive lymph through 
afferent collecting lymphatics, FALCs are not exposed to lymph but to the serous fluid entering 
through the mesothelial stomata. Collecting lymphatic vessels are found in the vicinity of 
FALCs to drain this fluid toward downstream lymph nodes [18]. See composition of FALCs 
in Figure 1A. 
 
1.2 The expression of IL-33 by FALC stromal cells support ILC2 function in FALCs  
Group 2 innate lymphoid  cells (ILC2) were first identified in FALCs of the mesenteric adipose 
tissue [7], where in response to IL-33, they secrete IL-5 which in turns enables innate-B cell 
proliferation and IgM secretion [7,10]. We found that GP38+CD31- FALC stromal cells 
produce IL-33, which is sequestrated in their nucleus [10]. Recent reports have now shown that  
IL-33 is also present within mesenchymal cells interspersed within, and mesothelial cells 
covering, adipose tissues. IL-33 is emerging as a key regulator of adipose tissue homeostasis 
by controlling type 2 immune cell recruitment to adipose tissue [22-26]. In particular stromal 
adipose IL-33 promotes ILC2 secretion of IL-4 and IL-13 [22,25,26] triggering the expression 
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of Ccl11 by mesenchymal adipose stromal cells which in turn increases recruitment of 
eosinophils to adipose tissue [23]. While PDGFRα+GP38+CD31- adipose stromal cells have 
been shown to support the differentiation of ILC2 progenitors [22], it is still not clear what 
promotes the recruitment/survival of ILC2 in FALCs and the adipose tissue stromal cell niche 
nor what proportion of ILC2 are found in FALCs compared to the rest of the adipose tissue. 
Interestingly, adipose tissues rich in FALCs, such as the omentum, secrete high amounts of IL-
33 compared to adipose depots poor in FALCs [10], suggesting that FALCs may concentrate 
IL-33 production and ILC2 action in adipose tissue. We recently confirmed by single-cell RNA 
sequencing the expression of IL-33 by mesothelial cells and mesenchymal cells [14]. 
 
1.3 The role of stromal cell derived retinoids at homeostasis 
All serous cavities are home to a population of self-renewing cavity-resident macrophages [27-
30], important for clearance of pathogens in serous cavities [27,31-33],  tissue repair [34,35] 
and Ig production by innate-B cells [36,37]. The maintenance and functional identity of these 
cavity-resident macrophages rely on the transcription factor GATA6 [36,38,39]. Gata6 
expression is induced by retinoic acid (RA), a derivative of retinol (vitamin A) [30,36]. 
Mesothelial cells and fibroblastic cells of the omentum and mesenteries express high levels of 
two rate limiting enzymes required for the conversion of retinol into RA, the retinaldehyde 
dehydrogenase 1 and 2 (Raldh1 and Raldh2) [30,36]. The transcription factor Wilms tumour 1 
(Wt1), which is required for the development of all visceral adipose tissues including the 
omental, pericardial and mesenteric depots [40] and is expressed by both PDGFRα- mesothelial 
cells and PDGFRα+ fibroblasts in the omentum and mesenteries drive the expression of Raldh1 
and Raldh2 [30]. Diphtheria-toxin mediated depletion of Wt1+ cells diminishes the frequency 
of serous-resident macrophages in the pericardial, pleural and peritoneal cavities confirming 
that Wt1 expressing cells are critical for the maintenance of  cavity-resident macrophages [30]. 
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Single-cell RNA sequencing analysis of omentum stroma confirmed that mesothelial cells, 
FALC cover cells and adipose stromal cells are competent to secrete RA while FALC FRCs 
are not [14]. Secretion of RA by FALC cover cells may establish an RA rich environment 
important for FALC B cell function. RA directly induces the expression of the gut homing 
molecules α4β7 Integrins and CCR9 by innate-B cells [41] while GATA6-dependent secretion 
of TGF-β2 by peritoneal macrophages promotes IgA class switching in innate-B cells [36,42]. 
RA is also important for the maintenance and function of innate-B cells via control of NFATc1 
expression [43,44]. See Figure 1B for RA production by FALC and adipose stromal cells. 
 
2 Signals controlling the formation of FALCs and their maturation  
2.1 During development and under homeostatic condition: 
FALCs are first found in human omentum during foetal development [45] and appear in the 
mouse mesenteries during the first week after birth [9]. Recruitment of a subset of RORγt-
dependent innate lymphoid cells (ILC) called lymphoid tissue inducer (LTi) cells expressing 
Lymphotoxin α (LTa) that engage the Lymphotoxin β receptor (LTβR) on mesenchymal cells 
is a critical step in the development of secondary lymphoid organs. In particular LTβR 
signalling induces CXCL13 expression by stromal cells of the lymph node anlagen, 
precipitating the recruitment of CXCR5+ LTi cells [46-50]. In contrast, the initiation of FALC 
formation is independent of RORγt and LTβR signalling [9,13]. While the formation of FALCs 
can be initiated in B and T cell deficient Rag2-/- mice, FALCs are absent in Rag2-/-Il2rγ-/- mice 
suggesting that a subset of ILCs different from LTi is required to trigger the initial formation 
of FALCs during normal development. FALCs do form in Cxcl13-/- mice [13], but fail to recruit 
B cells. The expression of Cxcl13 is not affected in LTα-/- mice [13], indicating that Cxcl13 
expression by FALC cover cells is not dependent on LTα/LTβR signalling. Additional work is 
required to determine what controls the expression of CXCL13 and the differentiation of FALC 
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cover cells. Interestingly, both RA [51] and interstitial fluid flow [52] have been shown to 
induce/reinforce CXCL13 expression during lymph node formation, two pathways which 
could be acting during FALC formation and which may have implications in disease states 
where there is increased serous fluid for example during peritoneal dialysis or malignant 
effusion [20]. 
FALCs are notably smaller and their number is reduced in Tnfr1-/-Tnfr2-/- mice [9] and 
in mice with a conditional deletion of Myeloid differentiation primary response 88 (MyD88) 
in Ccl19+ FRCs [15] indicating an important role for TNF signalling and innate-immune 
sensing for the development of FALCs. MyD88 signalling controls transcriptional 
reprogramming of FALC FRCs leading to increased expression of homeostatic and 
inflammatory chemokines and extra-cellular matrix proteins [15]. Germ free mice also show 
reduced numbers of FALCs [9], indicating that the presence of commensal microbes or their 
by-products sets an innate inflammatory tone sensed by FALC FRCs to form and mature a full 
complement of FALCs in the serous cavities. Sensing of the environment by FALC FRCs is 
likely to be facilitated by the constant flow of serous fluid through FALCs bringing in 
pathogens and antigens.   
2.2 Under acute inflammatory conditions  
During peritonitis, neutrophil and inflammatory monocyte rapidly enter FALCs to access the 
peritoneal cavity, while peritoneal contaminants are captured by FALCs [6,14,19,20]. In 
addition to the activation of existing FALCs, peritonitis leads to swift de novo FALC formation. 
This is dependent on the production of TNF by inflammatory monocyte/macrophages and 
TNFR-signalling in stromal cells [9]. The initial recruitment of inflammatory monocytes into 
FALCs requires MyD88 dependent signalling within Ccl19 expressing FALC FRC and the 
release of the monocyte chemoattractant CCL2 [15]. The cross-talk between monocyte/ 
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macrophage and FALC FRCs thus plays a critical role in de novo FALC formation. Natural 
Killer T cells (iNKT), a subset of T cells enriched in visceral adipose tissue [53], are required 
to induce neo-formation of FALCs during acute inflammation, an effect mediated through IL-
4 and IL-13 [9]. This suggests that a cross-talk between iNKT cells secreting IL-4/13 and 
FALC stromal cells expressing IL-4R is required to induce FALC formation. 
 
3. FALC stromal cells support B cell immune responses 
3.1 Innate-B cells 
Upon sensing of inflammatory or infectious signals, serous B cells migrate into FALCs where 
they undergo rapid proliferation and start to release large amounts of poly-reactive IgM to 
protect the serous space [10,11,54]. The absence of IL-33 signalling via genetic deletion of 
Il1rl1 (IL-33R) results in a failure to activate pericardial & mediastinal FALCs and a decrease 
in the levels of IgM locally within the pleural cavity in response to infection or allergic airway 
inflammation [10]. IL-33 does not act directly on FALC B cells but most likely on ILC2 [7], 
which respond by increased secretion of  IL-5 enabling rapid B cell proliferation and IgM 
secretion (Figure 2A) [10]. Thus stromal-derived IL-33 is important not only during 
homeostasis but early in response to infection or inflammation within the serous cavities, the 
mechanisms leading to release of IL-33 by FALC stromal cells are still to be elucidated. 
 
3.2 FALC FRC support T-cell dependent B cell immune responses 
FALCs support T-cell dependent immune responses, including Ig isotype switching [9,13,17], 
somatic hypermutation, and limited affinity maturation [13], despite the lack of identifiable 
follicular dendritic cells. Although FALCs do not develop proper germinal centres [13], B cells 
rapidly acquire a germinal centre–like phenotype that can be assessed by the expression of first 
apoptosis signal (FAS) and the T and B cell activation marker GL7. Recent work by Perez-
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Shibayama using FRC-restricted MyD88 ablation demonstrates that FALC FRC play a key 
role for CD4+ T cell–dependent B-cell activation, the initiation of a germinal centre reaction 
and IgG class switching during Salmonella infection. Recruitment of inflammatory monocytes 
into FALCs and bidirectional TNFR1/2 signalling between inflammatory monocytes and FRC 
mediates FRC activation and germinal centre formation (Figure 2B) [15]. Interestingly, the 
secretion of  IgM by FALC B cells is not affected by FRC-restricted MyD88 ablation [15] 
indicating that innate-B cell function and T cell-dependent B cell immune responses are 
supported by distinct FALC stromal cell population. In support of this, IgM producing B cells 
are found in the periphery of FALCs while IgMlow B cells are found in the centre of the cluster 
[9,10].   
 
Conclusions: 
Here we discussed how the structure and function of FALCs is supported by unique subsets of 
stromal cells. FALCs are emerging as critical regulators of serous cavity immune function at 
homeostasis and during infection and inflammation. Recent studies have shed considerable 
light on the importance of the adipose stromal cell niche for the establishment and function of 
the immune compartment of the serous cavities and adipose tissues. Future studies will benefit 
from genetic tools that will enable targeted deletion and modification of specific subsets of 
adipose stromal cells including those within FALCs. As immune-adipose tissues are 
increasingly recognised for the key roles they play in the regulation of whole body homeostasis, 
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Figure legends: 
Figure 1: Structure of FALCs. 
A, FALC stroma is made of two main stromal cell population: FALC FRCs expressing CCL19 
and FALC cover cells expressing CXCL13. Serous fluid enters FALCs through stomata made 
by the loose lining  of FALC cover cells and drain through collective lymphatic vessels in the 
vicinity of FALCs. Immune cells enter FALC from the circulation via HEVs and transit in and 
out of the serous cavity via stomata. B, Mesothelial cells, adipose stromal cells and FALC 
cover cells are competent to produce RA (1). RA induces the expression of GATA6 which is 
required to retain cavity-resident macrophages (2) and the secretion of TGF-β (3) which 
induces IgA class-switching (4). RA also acts directly on innate-B cells, inducing the 
expression of gut homing molecules (5) and is required for the expression of the transcription 
factor NFATc1 needed for the development and function of innate-B cells (6). 
 
Figure 2: FALC stromal cells support B cell immune responses 
A, FALC stromal cell support innate-B cell immune responses. CXCL13+ cover cells and 
CCL19+ FRCs express IL-33. Upon sensing of infectious/inflammatory signals (1), release of 
IL-33 (2) induces increased secretion of IL-5 by ILC2 (3) leading to innate-B cell activation 
and IgM secretion (4). B, FALC FRCs support T-cell dependent B cell immune response to 
peritoneal antigens. During serous infections, pathogens and antigens are filtered into FALCs 
(1) where MyD88 mediated-innate sensing of pathogens by CCL19+ FRCs (2) trigger CCL2 
secretion (3) and inflammatory monocyte recruitment (4). FALC FRC-monocyte cross-talk 
through TNF-TNFR signaling (5) is required for T-B cell interactions (6), germinal center 




















































B. FALC FRCs support T-cell dependent B cell immune response to peritoneal antigens
1. Pathogens/Antigens
